1. Home
  2. GLDG vs NERV Comparison

GLDG vs NERV Comparison

Compare GLDG & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

HOLD

Current Price

$0.94

Market Cap

205.6M

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.35

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDG
NERV
Founded
2009
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
210.1M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
GLDG
NERV
Price
$0.94
$4.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.75
$10.50
AVG Volume (30 Days)
577.1K
150.3K
Earning Date
04-10-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$1.76
52 Week High
$2.27
$12.46

Technical Indicators

Market Signals
Indicator
GLDG
NERV
Relative Strength Index (RSI) 56.52 47.75
Support Level $0.86 $3.80
Resistance Level $0.98 $4.70
Average True Range (ATR) 0.04 0.34
MACD 0.01 0.00
Stochastic Oscillator 88.55 50.00

Price Performance

Historical Comparison
GLDG
NERV

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. Its principal projects are the La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; the Sao Jorge Gold Project, located in Brazil; and its interest in the Whistler Gold-Copper Project, located in Alaska, United States. Additionally, the company has several other projects in its portfolio, such as the Yellowknife Gold Project, Cachoeira Gold Project, Surubim Gold Project, Yarumalito Gold Project, Rea Uranium Project, etc. The firm has two operating segments, with U.S. GoldMining as one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: